Centene Corp.
- CNC ยท NYSE
- Hospital & Medical Service Plans
- St Louis, MO
- 61,100 employees
- CIK 0001071739
Updated from SEC filings through
Top things to know
Executives
- Sarah M. London Chief Executive Officer of Centene 8-K, 2026-10-26
- Sarah London Chief Executive Officer 8-K, 2026-05-15
- Christopher Neczypor Chief Financial Officer 8-K, 2026-08-17
- Drew Asher Chief Financial Officer 8-K, 2026-05-15
- Andrew Lynn Asher Chief Financial Officer 4, 2026-03-17
- Andrew L. Asher Executive Vice President, Chief Financial Officer 10-K, 2026-02-17
What leadership is saying
“Solid underlying fundamentals within our core businesses have powered a faster recovery to our earnings trajectory than previously anticipated”
Earnings press release (8-K Ex. 99.1), filed October 26, 2026
Centene Corp is a U.S. public company in hospital & medical service plans (SIC 6324), headquartered in St Louis, MO. It trades as CNC on NYSE. Revenue was $195B in the fiscal year ending December 31, 2025, +19.4% from the year before. It reported about 61,100 employees. Sarah M. London is Chief Executive Officer of Centene.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $195B 10-K, 2026-02-17 | $163B 10-K, 2026-02-17 | $154B 10-K, 2026-02-17 | $145B 10-K, 2025-02-18 | $126B 10-K, 2024-02-20 |
| Operating income | -$7.6B 10-K, 2026-02-17 | $3.2B 10-K, 2026-02-17 | $2.9B 10-K, 2026-02-17 | $1.3B 10-K, 2025-02-18 | $1.8B 10-K, 2024-02-20 |
| SG&A | $12.9B 10-K, 2026-02-17 | $12.4B 10-K, 2026-02-17 | $12.6B 10-K, 2026-02-17 | $11.6B 10-K, 2025-02-18 | $9.6B 10-K, 2024-02-20 |
| Net income | -$6.7B 10-K, 2026-02-17 | $3.3B 10-K, 2026-02-17 | $2.7B 10-K, 2026-02-17 | $1.2B 10-K, 2025-02-18 | $1.3B 10-K, 2024-02-20 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Sarah M. London CEO of Centene Corporation | Chief Executive Officer of Centene | 8-K, 2026-10-26 |
| Sarah London | Chief Executive Officer | 8-K, 2026-05-15 |
| Frederick H. Eppinger | Board member (per proxy) bio: Director, President and Chief Executive Officer | DEF 14A, 2026-03-26 |
| Christopher Neczypor | Chief Financial Officer | 8-K, 2026-08-17 |
| Drew Asher | Chief Financial Officer | 8-K, 2026-05-15 |
| Andrew Lynn Asher | Chief Financial Officer | 4, 2026-03-17 |
| Andrew L. Asher | Executive Vice President, Chief Financial Officer | 10-K, 2026-02-17 |
| Susan Raye Smith | Chief Operating Officer | 4, 2026-06-15 |
| Michael A. Carson | Group President, Medicare&Spec | 4, 2026-06-02 |
| Daniel P. Finke | Group President, Markets&Comm | 3, 2026-05-18 |
| Tanya McNally Chief People Officer at Centene Corporation | Chief People Officer | 8-K, 2026-05-15 |
| Daniel Finke Group President, Markets and Commercial at Centene | Group President, Medicaid and Marketplace | 8-K, 2026-05-15 |
| Susan Smith | Chief Operations Officer | 8-K, 2026-05-15 |
| Theodore Pienkos | Corporate Controller and Chief Accounting Officer | 8-K, 2026-05-15 |
| Michael Carson Healthcare CEO, Board Director, Advisor, Investor | Group President, Medicare and Specialty | 8-K, 2026-05-15 |
| Tanya M. Mcnally | Chief People Officer | 4, 2026-04-16 |
What Centene Corp does
Our mission is to transform the health of the communities we serve, one person at a time. As the nation's largest managed care company focused on underserved populations, Centene is committed to helping people live healthier lives. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 495.1 million (as of October 23, 2026) | 10-Q, October 27, 2026 |
|---|---|---|
| Public float | $26.7B (as of June 30, 2025) | 10-K, February 17, 2026 |
| Reportable segments | 4 (period ending September 30, 2026) | 10-Q, October 27, 2026 |
| Latest proxy statement | Meeting May 12, 2026 (filed March 26, 2026) | DEF 14A, March 26, 2026 |
| Auditor | Kpmg LLP (St. Louis, MO) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| August 26, 2026 | Christopher Koster Secretary & General Counsel | Sale | 56,500 | $3.8M | Form 4, August 27, 2026 |
| August 18, 2026 | Christopher Koster Secretary & General Counsel | Sale | 47,603 | $3.1M | Form 4, August 19, 2026 |
| June 10, 2026 | Kenneth A. Burdick Director | Sale | 80,000 | $5.2M | Form 4, June 11, 2026 |
| December 4, 2025 | Kenneth A. Burdick Director | Sale | 66,007 | $2.6M | Form 4, December 5, 2025 |
| August 8, 2025 | Sarah London Chief Executive Officer | Buy | 19,230 | $490K | Form 4, August 11, 2025 |
| July 28, 2025 | Theodore R. Samuels II Director | Buy | 9,000 | $249K | Form 4, July 29, 2025 |
Recent 8-K events
- 8-K filed 2026-10-27
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-08
- Item 8.01 Other events
- 8-K filed 2026-09-16
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-17
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-07-29
- Item 8.01 Other events
- 8-K filed 2026-07-28
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-22
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-15
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-04-28
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-03-24
- Item 5.02 Departure or appointment of directors or officers; compensation
Frequently asked questions about Centene Corp
- What does Centene Corp do?
- In its own words, from Item 1 of its 10-K: "Our mission is to transform the health of the communities we serve, one person at a time. As the nation's largest managed care company focused on underserved populations, Centene is committed to helping people live healthier lives. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace."
- What is Centene Corp's revenue?
- $195B for the fiscal year ending December 31, 2025, from its 10-K filed February 17, 2026.
- Is Centene Corp profitable?
- Centene Corp reported net income of -$6.7B for the fiscal year ending December 31, 2025.
- How many employees does Centene Corp have?
- About 61,100 as of February 17, 2026, as stated in its annual report.
- Who is the CEO of Centene Corp?
- Sarah M. London, Chief Executive Officer of Centene, as named in a 8-K filed October 26, 2026.
- Who is the CFO of Centene Corp?
- Christopher Neczypor, Chief Financial Officer, as named in a 8-K filed August 17, 2026.
- Where is Centene Corp headquartered?
- St Louis, MO.
- What is Centene Corp's stock ticker?
- CNC on NYSE.
- What industry is Centene Corp in?
- Hospital & Medical Service Plans, SIC code 6324.
- What is Centene Corp's website?
- centene.com. Investor relations: https://investors.centene.com.
- When does Centene Corp report earnings next?
- December 31, 2026. Source: ir_events.
- Is Centene Corp a public company?
- Yes. Centene Corp files with the SEC under CIK 0001071739 and trades as CNC.
- Who audits Centene Corp?
- Kpmg LLP, St. Louis, MO, as named in its latest annual report (10-K).
- How many shares of Centene Corp are outstanding?
- 495.1 million shares as of October 23, 2026, from its 10-Q filed October 27, 2026.
- What is Centene Corp's public float?
- $26.7B as of June 30, 2025, as reported on the cover of its 10-K filed February 17, 2026.
- How many business segments does Centene Corp report?
- 4 reportable segments for the period ending September 30, 2026, from its 10-Q filed October 27, 2026.
- When is Centene Corp's annual shareholder meeting?
- May 12, 2026, per its proxy statement (DEF 14A) filed March 26, 2026.
- Have Centene Corp insiders traded stock recently?
- Since July 28, 2025, officers and directors reported 4 open-market sales worth about $14.6M and 2 purchases worth about $739K on Forms 4 and 5. The most recent: Christopher Koster (Secretary & General Counsel) sold 56,500 shares on August 26, 2026.